• Je něco špatně v tomto záznamu ?

MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115-126

J. Neuzil, J. Rohlena, L. Werner, Z. Bielcikova

. 2023 ; 15 (18) : . [pub] 20230908

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23015296

A recent paper published in Nature Medicine reported on the Phase I clinical trial of a mitochondria-targeting anti-cancer agent IACS-01059 in patients with acute myeloid leukemia (AML) and solid tumors [...].

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23015296
003      
CZ-PrNML
005      
20231020093448.0
007      
ta
008      
231010s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/cancers15184476 $2 doi
035    __
$a (PubMed)37760446
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Neuzil, Jiri $u School of Pharmacy and Medical Science, Griffith University, Southport, Qld 4222, Australia $u Institute of Biotechnology, Czech Academy of Sciences, 252 50 Prague, Czech Republic $u Faculty of Science, Charles University, 128 00 Prague, Czech Republic $u First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic $1 https://orcid.org/0000000224782460 $7 xx0115772
245    10
$a MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115-126 / $c J. Neuzil, J. Rohlena, L. Werner, Z. Bielcikova
520    9_
$a A recent paper published in Nature Medicine reported on the Phase I clinical trial of a mitochondria-targeting anti-cancer agent IACS-01059 in patients with acute myeloid leukemia (AML) and solid tumors [...].
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Rohlena, Jakub $u Institute of Biotechnology, Czech Academy of Sciences, 252 50 Prague, Czech Republic $1 https://orcid.org/0000000154276502 $7 xx0166966
700    1_
$a Werner, Lukas $u Institute of Biotechnology, Czech Academy of Sciences, 252 50 Prague, Czech Republic
700    1_
$a Bielcikova, Zuzana $u First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic $u General University Hospital, Charles University, 128 08 Prague, Czech Republic $1 https://orcid.org/0000000184349848 $7 xx0225233
773    0_
$w MED00173178 $t Cancers $x 2072-6694 $g Roč. 15, č. 18 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37760446 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231010 $b ABA008
991    __
$a 20231020093442 $b ABA008
999    __
$a ok $b bmc $g 1997085 $s 1201658
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 15 $c 18 $e 20230908 $i 2072-6694 $m Cancers $n Cancers $x MED00173178
LZP    __
$a Pubmed-20231010

Najít záznam

Citační ukazatele

Možnosti archivace